Drug Profile
Amlexanox - Abeona Therapeutics
Alternative Names: Amlexanox mucoadhesive liquid - PlasmaTech Biopharmaceuticals; LexaGardLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Access Pharmaceuticals
- Developer Abeona Therapeutics
- Class Aminopyridines; Anti-inflammatories; Antiallergics; Antiulcers; Small molecules
- Mechanism of Action Histamine release inhibitors; Leukotriene inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Barrett's oesophagus; Oesophagitis
Most Recent Events
- 24 May 2018 Discontinued - Clinical-Phase-Unknown for Barrett's oesophagus in USA (PO)
- 24 May 2018 Discontinued - Clinical-Phase-Unknown for Oesophagitis in USA (PO)
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Barrett's-oesophagus in USA (PO, Liquid)